Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses.
Nucleic Acids Res
; 50(8): e47, 2022 05 06.
Article
in En
| MEDLINE
| ID: mdl-35166837
Full text:
1
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Limits:
Animals
/
Humans
Language:
En
Journal:
Nucleic Acids Res
Year:
2022
Type:
Article
Affiliation country:
China